Functional opsonins against 3 microorganisms which vary in dependence on heat stable specific antibody (HSO) and heat labile complement (HLO) were measured in WA and age matched C by an adaptation of the in vitro bactericidal assay. Normal phagocytes were incubated with bacteria and fresh or heat inactivated serum at various dilutions and viable colonies determined over 2 hours. Sera were collected for 4 weeks following administration to WA and C of acellular vaccine containing streptococcal and staphylococcal protein and pneumococcal polysaccharide. Opsonization and killing of 5. pyogenes was primarily dependent upon HSO since heated sera of WA and C supported killing of this organism. Both sera showed increased opsonization of 2. pvonenes following vaccination. Opsonization of D. Bdepends mainly on HLO; heated sera from WA and C did not support its killing. Unheated C sera showed a small increase of killing following vaccination but there was no change with WA sera. HSO influenced killing of 2 . aureus to a moderate degree; the older WA was equal to C whereas the younger WA developed normal levels with time. Three of four non-related boys presented with thrombocytopenia, eczema, bloody diarrhea and frequent infections. The fourth initially had thrombocytopenia only, was splenectomized, and subsequently developed repeated infections and eczema. Immunoglobulins were variably abnormal. Antibody production to bacteriophage OX 174 (a protein antigen) was abnormal with low primary and severely impaired secondary response. No IgG antibody was formed. Lymphocyte transformation with non-specific mitogens and allogeneic cells was significantly impaired and the number of E-rosettes diminished.
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Volumetric size of platelets was reduced to 50%. Except in the splenectomized patient, autologous platelet survival time was normal. In all patients, in vivo and in vitro platelet function when corrected for platelet size was normal. Since megakaryocyte mass was adequate, thrombocytopenia must result from ineffective thrombocytopoesis. Red blood cell (RBC) size was also reduced.
The abnormal B and T-cell function, the ineffective platelet production and decreased size of platelets and RBC in this X-linked disease suggests that a single genetic defect is expressed functionally in all stem cell derivatives.
w, Dept.of Ped., State Univ. of N.Y. at Buffalo.
A comparative evaluation of serum and secretory antibody responses to influenza A2/HK, para-influenza and other viruses was undertaken in groups of children with acute viral pharyngitis, croup or bronchiolitis. The techniques of tissue culture infectivity, neutralizing antibody assay, and indirect immunofluorescence were employed to recover infectious virus from the respiratory tract and to characterize specific antibody response in the serum and nasopharynx. Serologic evidence of infection or recovery of influenza A~/HK or parainfluenza 1 and 3 viruses was most frequently observed in patients with croup. The sequence of appearance and the levels of serum yG, yA and yM influenza and para-influenza antibodies in patients with pharyngitis, croup or bronchiolitis were generally similar. However, nasopharyngeal antibody levels to influenza or para-influenza viruses were significantly lower in patients with croup when compared to the levels obtained in patients with pharyngitis or bronchiolitis. Furthermore, nasopharyngeal antibody response to influenza virus was conspicuously absent in a few patients with severe influenza AZ/HK croup who required tracheostomy on hospitalization. The reduction or absence of nasopharyngeal antibody levels was not related to virus-antibody complexes and no change was observed in nasopharyngeal antibody levels for as long as 3-4 months after recovery from the infection. These observations suggest that alterations of secretory immune response in the respiratory tract may be related to the pathogenesis of viral croup. A male infant in a family with the autosomal form of SClD was delivered vaginally. SClD was diagnosed on cord blood and later confirmed. He was kept free of infection by reverse isolation in a laminar flow hood from age 1 week until transplant 5 months later.
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Before transplant, decontamination was begun with chlorhexidine for the skin and oral cephaloridine, neomycin and mycostatin for the upper respiratory and GI tracts. Within 3 days and thereafter all cultures (including washed stools) revealed no growth.
The infant has received 2 marrow grafts from an unrelated female donor differing by one allele but matched by MLC. Ten days after the lst, the maculopapular rash o f graft vs host(GVH) began. Eosinophilia and hepatosplenomegaly are the only other signs of GVH. The patient shows early reconstitution:palpable nodes, synthesis of IgM and IgA, weak PHA responses, lymphocytes with donor specificity. Previous marrow grafts in SClD using an unrelated donor have led to severe GVH with fatal infectious complications. This infant has had mild GVH without infection.
ENHANCEMENT OF IN VITRO CELLULAR IMMUNE RESPONSE BY L-TETRA-MISOLE. Henry F. Pabst, Joan A. Crawford (Intr. by E.E. McCoy). Univ. of Alberta, Dept. of Ped., Edmonton, Alberta.
L-tetramisole, a potent antihelminthic, has recently been shown to enhance the ability of anergic cancer patients to both become sensitized and respond to the contact sensitizing agent 2,4-DNCB (New Engl. J. Med. 289: 354, 1973 ). L-tetramisole is hypothesized to stimulate the T-cell system ( i b i d , 375), and we have tested this hypothesis by examining the effects of L-tetramisole on the response of normal human lymphocytes to T-cell stimulating antigens. Following ficollhypaque isolation, 2 x 1 0~ lymphocytes were cultured in triplicate for 5 or 8 days, with or without specific antigens (candida, measles virus, or PPD), in the presence or absence of Ltetramisole (1 mg/culture, optimal dose), in 4 ml RPMI 1640 containing 20% autologous serum. Each culture received 2 uc 3~-thymidine 24 hours prior to harve ting, and i n v i t r o cellular immune response was measured as % uptake. Cells cultured in the presence of L-tetramisole showed significantly greater response to each of the three antigens than those cultured without the drug (p<0.01).
Cells from donors with pre-existing antigen immunity responded within 5 days, but those with mild or absent pre-existing sensitivity responded after 8 days. Our results clearly indicate an i n v i t r o immunostimulant activity of L-tetramisole, and suggest the potential importance of this drug both in the treatment of patients with primary cellular immunity defects and in the management of cancer.
